Literature DB >> 12798405

Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas.

Ryozo Miyamoto1, Narikazu Uzawa, Shunya Nagaoka, Yasushi Hirata, Teruo Amagasa.   

Abstract

Amplification and overexpression of cyclin D1 (CCND1) have been reported as independent prognostic indicators of several tumors. To investigate the association between CCND1 amplification and overexpression in oral squamous cell carcinomas (OSCCs), and to determine which is more reliable as a prognostic indicator, fluorescence in situ hybridization (FISH) on fine-needle aspiration (FNA) biopsies and immunohistochemistry were performed on 41 primary OSCCs (26 males, 15 females; mean age; 58.4 years, range 21-89 years). Thirteen patients were stage I, 13 were stage II, nine were stage III, and six were stage IV. CCND1 amplification and overexpression was detected in 13 (31.7%) and 27 (65.9%) of 41 cases. CCND1 was overexpressed in all cases showing CCND1 amplification. On the other hand, CCND1 overexpression was also detected in 14 of 28 cases (50.0%) lacked such amplification. Statistical analysis showed that the correlation between CCND1 overexpression and decreased survival just failed to reach statistical significance, and CCND1 amplification and nodal status were independent prognostic indicators. In conclusion, it will be necessary to investigate the other pathways that regulate CCND1 expression besides CCND1 amplification. From the present study, CCND1 amplification is a more reliable prognostic indicator than CCND1 overexpression in OSCCs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798405     DOI: 10.1016/s1368-8375(03)00048-4

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  28 in total

Review 1.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

2.  The role of E-cadherin/beta-catenin complex and cyclin D1 in head and neck squamous cell carcinoma.

Authors:  Nam Yong Do; Sung Yong Park; Sung Chul Lim
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

Review 3.  Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review.

Authors:  Carolin M Grimminger; Peter V Danenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-09       Impact factor: 2.503

4.  Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.

Authors:  Madhav Sankunny; Rahul A Parikh; Dale W Lewis; William E Gooding; William S Saunders; Susanne M Gollin
Journal:  Genes Chromosomes Cancer       Date:  2013-11-25       Impact factor: 5.006

5.  CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.

Authors:  Henning Hanken; Alexander Gröbe; Georg Cachovan; Ralf Smeets; Ronald Simon; Guido Sauter; Max Heiland; Marco Blessmann
Journal:  Clin Oral Investig       Date:  2013-03-15       Impact factor: 3.573

Review 6.  Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives.

Authors:  Simonetta Ausoni; Paolo Boscolo-Rizzo; Bhuvanesh Singh; Maria Cristina Da Mosto; Giacomo Spinato; Giancarlo Tirelli; Roberto Spinato; Giuseppe Azzarello
Journal:  Cancer Metastasis Rev       Date:  2016-09       Impact factor: 9.264

7.  Prognostic utility of chromosomal instability detected by fluorescence in situ hybridization in fine-needle aspirates from oral squamous cell carcinomas.

Authors:  Hiroaki Sato; Narikazu Uzawa; Ken-Ichiro Takahashi; Kunihiro Myo; Yoshio Ohyama; Teruo Amagasa
Journal:  BMC Cancer       Date:  2010-05-06       Impact factor: 4.430

8.  Cyclin d1 gene expression in oral mucosa of tobacco chewers"-an immunohistochemical study.

Authors:  Maharudrappa Basnaker; Srikala Sp; Satish Bnvs
Journal:  J Clin Diagn Res       Date:  2014-05-15

Review 9.  DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review.

Authors:  Yu Chen; Chu Chen
Journal:  Head Neck       Date:  2008-10       Impact factor: 3.147

10.  Elevated cyclin D1 expression is predictive for a benefit from TPF induction chemotherapy in oral squamous cell carcinoma patients with advanced nodal disease.

Authors:  Lai-Ping Zhong; Dong-Wang Zhu; William N William; Ying Liu; Jie Ma; Cheng-Zhe Yang; Xiao Yang; Li-Zhen Wang; Jiang Li; Jeffrey N Myers; J Jack Lee; Chen-Ping Zhang; Zhi-Yuan Zhang
Journal:  Mol Cancer Ther       Date:  2013-03-20       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.